Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Clinical trial NCT02140736 · COMPLETED

Trial details

NCT number: NCT02140736
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Chemotherapy-induced Symptomatic Anemia Solid Tumors Malignant Hemopathies Lymphomas Myelomas

Start date: 2009-09-01
Primary completion: 2011-08-01
Enrollment: 2333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.